Status:
COMPLETED
COVID-19 Pandemic Burden in Severe Mental Disease Patients
Lead Sponsor:
Federico II University
Conditions:
Psychological Distress
COVID
Eligibility:
All Genders
18-70 years
Brief Summary
Despite being originated in Wuhan, in the China mainland region of the Hubei, Italy has been the hardest-hit country in the world by the COVID-19 pandemic during the month of March. Due to the uncont...
Eligibility Criteria
Inclusion
- DSM-5 Diagnosis of Schizophrenia or Psychosis Spectrum; Bipolar Disorder; REcurrent Major Depressive Disorder
- Linguistic and cognitive ability to complete the rating scales
- Written informed consent
- Psychopathological compensation at last clinical evaluation on January-February 2020
Exclusion
- SARS-CoV-2 positive, suspected positive, or in recent close contact with positive ones
- Not under strict quarantine, due to work reasons or to any other reason allowing to overcome quarantine
- Current or recent hospitalization (i.e. on March-April), for any reason
- Intellectual disability
- Psychiatric disturbances secondary to general medical conditions or substances
- Serious medical conditions with infaust prognosis or severely affecting the quality of life
- Living in Northern Italy
- Adjunctive Exclusion Criteria for the General Population and Caregivers:
- Psychiatric Disorder, of any type
- Adjunctive Exclusion Criteria for the General Population:
- First degree relative or caregiver of a psychiatric patient
Key Trial Info
Start Date :
April 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 25 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04357769
Start Date
April 10 2020
End Date
April 25 2020
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Naples "Federico II"
Napoli, Italy, 80131